FIELD: medicine.
SUBSTANCE: for estimating clinical effectiveness, patients suffering chronic conditions of nose and accessory sinuses of nose are examined for a degree of nonspecific resistance of a nasal mucosa by calculating a thiol-disulphide balance K=SH/SS, and a number of SH and -SS groups in a nasal secretion. The values K=1.2-1.9 enables to estimate a degree of nonspecific resistance of the nasal mucosa as low, and clinical effectiveness is considered to be negative. If K=2.0-2.7, a degree of nonspecific resistance is estimated as low, clinical effectiveness is positive, however requiring to be prolonged. The value K=2.8-3.5 provides a high degree of nonspecific resistance and positive clinical effectiveness.
EFFECT: invention allows precise and quick estimation of clinical effectiveness.
5 tbl, 3 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF CHILDREN'S CHRONIC INFLAMMATORY NOSE DISEASES | 1996 |
|
RU2127133C1 |
| METHOD OF EVALUATING THE EFFICIENCY OF MEDICAMENTAL THERAPY OF ACUTE EXACERBATIONS OF CHRONIC PURULENT SINUSITIS | 2015 |
|
RU2600645C2 |
| PREDICTION METHOD OF POLYPOUS RHINOSINUSITIS RELAPSE RISK FOR PREVENTIVE THERAPY INDICATIONS | 2007 |
|
RU2338205C1 |
| METHOD OF TREATING CHRONIC RECURRING INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINISES BY METHOD OF ENDONASAL AUTOLYMPHOCYTO THERAPY | 2009 |
|
RU2403071C1 |
| METHOD FOR TREATING CHRONIC POLYPOUS RHINOSINUSITIS | 2000 |
|
RU2163097C1 |
| METHOD FOR EVALUATING THE STATE OF LOCAL IMMUNITY OF NASAL CAVITY MUCOSA IN RHINOLOGICAL PRACTICE | 2006 |
|
RU2297633C1 |
| METHOD OF POLYPOUS RHINOSINUSITIS TREATMENT | 2017 |
|
RU2646806C1 |
| METHOD FOR NON-INVASIVE TREATMENT OF PARANASAL RHINOSINUSITIS IN ADULTS AND CHILDREN | 2012 |
|
RU2509576C2 |
| METHOD FOR SELECTING TARGETED THERAPY IN CHRONIC T2-INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINUSES | 2023 |
|
RU2824263C1 |
| REHABILITATION METHOD AND DRUG FOR CHILDREN WITH CHRONIC RHINOSINUSITIS | 2008 |
|
RU2401119C2 |
